Dinoprost tromethamine in Horses (Equis) | Vetlexicon
equis - Articles

Dinoprost tromethamine

ISSN 2398-2977


Introduction

Name

  • Dinoprost tromethamine.

Class of drug

  • Prostaglandin.
  • Prostaglandin F2α (PGF2α).

Description

Chemical name

  • 2-amino-2-(hydroxymethyl)propane-1,3-diol.

Molecular formula

  • C20H34O5.C4H11NO3; C24H45NO8.

Molecular weight

  • 475.62.

Physical properties

  • Supplied as a clear, aqueous solution for injection.

Uses

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Administration

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Pharmacokinetics

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Precautions

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Withdrawal Periods

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Adverse Reactions

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Further Reading

Publications

Refereed papers

  • Recent references from PubMed and VetMedResource.
  • Barker K J, Mateu Sánchez S, Serrano Y R, Lacey F M & Crabtree J R (2019) Prostaglandin F2 alpha-induced maternal behaviour for fostering orphan foals and for mares demonstrating foal rejection. Equine Vet J 61, S53.
  • Holland B & Pinto C R F (2008) Luteal function and ovulation in mares treated with PGF2a during early and mid-diestrus. Reprod Domest Anim 43 (Suppl 3), 111 Wiley.
  • Barker C, Echeverria K & Davis M (2006) Effects of different doses of PGF2 on luteal function and on the subsequent estrous cycle. Anim Reprod Sci 94, 207–209.
  • Bergfelt D R, Pierson R A & Ginther O J (2006) Regression and resurgence of the CL following PGF2alpha treatment 3 days after ovulation in mares. Theriogenology 65 (8), 1605-1619 PubMed.
  • Klem M E Jr, Kreider J L, Harms P G, Potter G D, Kraemer D C & Godke R A (1982) Induction of parturition in the mare with prostaglandin F2 alpha. Prostaglandins 24 (1), 89-96 PubMed.

Other sources of information

  • Staempfli S A (2011) Pharmacologic Manipulation of Reproduction: Prostaglandins. In: Equine Reproduction. 2nd edn. Eds: McKinnon A O, Squires E L, Vaala W E & Varner D D. Wiley-Blackwell. pp 1797-1804.
  • The NOAH Compendium of datasheets of licensed veterinary medicines. Available at: https://www.noahcompendium.co.uk.
  • Veterinary Medicines Directorate. Adverse Reaction Reporting. Available at: https://www.vmd.defra.gov.uk.
  • Veterinary Medicines Directorate. Questions and Answers on FDA's Adverse Event Reporting System (FAERS). Available at: https://www.fda.gov/drugs.